Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.475
+0.055 (3.87%)
At close: Apr 28, 2026, 4:00 PM EDT
1.480
+0.005 (0.34%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $392.56 million as of April 28, 2026. Its market cap has increased by 29.39% in one year.
Market Cap
392.56M
Enterprise Value
433.44M
1-Year Change
29.39%
Ranking
Category
Stock Price
$1.48
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $969.66M to $392.56M, a decrease of -59.52%. That is a compound annual growth rate of -10.88%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Century Therapeutics | 399.73M |
| Niagen Bioscience | 395.62M |
| Immuneering | 390.77M |
| Enanta Pharmaceuticals | 386.25M |
| Lineage Cell Therapeutics | 386.09M |
| Rocket Pharmaceuticals | 384.11M |
| YD Bio | 383.95M |
| Puma Biotechnology | 383.61M |